Highlights and Quick Summary
- Weighted Average Shares Growth for the quarter ending December 31, 2022 was 237.27% (a 624.27% increase compared to previous quarter)
- Year-over-year quarterly Weighted Average Shares Growth increased by 228.9%
- Annual Weighted Average Shares Growth for 2022 was -70.79% (a -112.84% decrease from previous year)
- Annual Weighted Average Shares Growth for 2022 was 551.48% (a -878.93% decrease from previous year)
- Annual Weighted Average Shares Growth for 2021 was -70.8% (a -100.02% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Weighted Average Shares Growth of Benitec Biopharma Limited
Most recent Weighted Average Shares Growthof BNTC including historical data for past 10 years.Interactive Chart of Weighted Average Shares Growth of Benitec Biopharma Limited
Benitec Biopharma Limited Weighted Average Shares Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 237.27% | 32.76% | 90.27% | 72.14% | -70.79% |
| 2021 | 90.05% | -96.31% | 84115.69% | 87809.26% | -70.8% |
| 2020 | 400.7% | 89.47% | -98.96% | -99.89% | -99.85% |
| 2019 | – | – | – | -99.9% | -70.8% |
| 2018 | – | – | – | – | -70.79% |
| 2017 | – | – | – | 9646.67% | -99.9% |
| 2016 | – | – | – | 9478.43% | 23.22% |
| 2015 | – | – | – | – | 27.78% |
| 2014 | – | – | – | – | -91.33% |
| 2013 | – | – | – | – | 1053.07% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology